Literature DB >> 22325372

Primary clear cell adenocarcinoma of the bladder with recurrence: a case report and literature review.

Ji Lu1, Zhihui Xu, Fengming Jiang, Yan Wang, Yuchuan Hou, Chunxi Wang, Qihui Chen.   

Abstract

Clear cell carcinoma of the bladder is a rare tumor of the bladder. There are few reports available on this rare disease, and no cases with recurrence were reported. Here we present a case of 68-year-old woman with primary clear cell carcinoma of the bladder, who underwent repeat TUR-BT and tumor recurrence. We also reviewed the previous treatments and prognoses in previous case reports and evaluate the proper treatment for this disease. Once the diagnosis is determined, the radical surgery should be recommended. The recurrence is not prevented based on post-TUR intravesical therapy.

Entities:  

Mesh:

Year:  2012        PMID: 22325372      PMCID: PMC3305464          DOI: 10.1186/1477-7819-10-33

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  23 in total

1.  Multicentric clear cell adenocarcinoma in the urinary bladder and the urethral diverticulum: evidence of origin of clear cell adenocarcinoma of the female lower urinary tract from Müllerian duct remnants.

Authors:  K T Mai; H M Yazdi; D G Perkins; C Morash; J Green
Journal:  Histopathology       Date:  2000-04       Impact factor: 5.087

Review 2.  A case of adenocarcinoma with clear cell carcinoma of the bladder.

Authors:  K Ito; H Yamanaka; Y Ichinose; J Kurihara
Journal:  Hinyokika Kiyo       Date:  1999-09

3.  Clear cell adenocarcinoma of the urinary bladder within a diverticulum.

Authors:  Alireza Moinzadeh; Jerilyn Latini; Karim J Hamawy
Journal:  Urology       Date:  2003-07       Impact factor: 2.649

4.  Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.

Authors:  Esther Oliva; Mahul B Amin; Rafael Jimenez; Robert H Young
Journal:  Am J Surg Pathol       Date:  2002-02       Impact factor: 6.394

5.  Mesonephric adenocarcinoma of the bladder.

Authors:  J A Dow; J D Young
Journal:  J Urol       Date:  1968-10       Impact factor: 7.450

Review 6.  Clear cell adenocarcinoma of the urinary bladder inducing acute renal failure.

Authors:  Yoh Matsuoka; Tatsuya Machida; Kaoru Oka; Kazuhiro Ishizaka
Journal:  Int J Urol       Date:  2002-08       Impact factor: 3.369

7.  Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder.

Authors:  A F Kantor; P Hartge; R N Hoover; J F Fraumeni
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

Review 8.  Clear cell adenocarcinoma of the bladder and urethra. A report of three cases and review of the literature.

Authors:  R H Young; R E Scully
Journal:  Am J Surg Pathol       Date:  1985-11       Impact factor: 6.394

Review 9.  Clear cell adenocarcinoma of the bladder in a male patient: clinicopathologic analysis of a case.

Authors:  Gianbattista Signori; Gerolamo Tonini; Vito Aulenti; Bassam Taher; Farshid-Kalantary Rad; Michelangelo Tosana; Marco Ungari; Fausto Zorzi
Journal:  Urol Int       Date:  2003       Impact factor: 2.089

10.  The present and future burden of urinary bladder cancer in the world.

Authors:  Martine Ploeg; Katja K H Aben; Lambertus A Kiemeney
Journal:  World J Urol       Date:  2009-02-15       Impact factor: 4.226

View more
  10 in total

1.  Clear cell adenocarcinoma of the bladder with intravesical cervical invasion.

Authors:  Daniel Marchalik; Jayashree Krishnan; Mohan Verghese; Krishnan Venkatesan
Journal:  BMJ Case Rep       Date:  2015-06-24

2.  Comparison of two patients presenting with the clear cell variant of urothelial cell carcinoma of the urinary bladder: laser-assisted partial cystectomy for local disease versus chemotherapy for locally advanced disease.

Authors:  James P Blackmur; Nadja Melquiot; Katherine E Robertson; Seamus Teahan
Journal:  BMJ Case Rep       Date:  2019-06-16

3.  Molecular profiling of clear cell adenocarcinoma of the urinary tract.

Authors:  Chieh-Yu Lin; Atif Saleem; Henning Stehr; James L Zehnder; Benjamin A Pinsky; Christian A Kunder
Journal:  Virchows Arch       Date:  2019-08-02       Impact factor: 4.064

4.  Primary clear cell carcinoma of urinary bladder: A case report.

Authors:  Mahmoudreza Moradi; Shahram Shojaei; Kaveh Kaseb; Haress Rezaee
Journal:  Urol Case Rep       Date:  2017-10-19

5.  Concordant clear cell "mesonephric" carcinoma of the bladder and lung adenocarcinoma with clear cell features - multiple primaries versus metastatic neoplasms: a case report.

Authors:  Sarmad H Jassim; Amer Khiyami; Jane K Nguyen; Santhi Ganesan; Joseph Tomashefski; Joram Sawady
Journal:  J Med Case Rep       Date:  2017-05-12

6.  Rare Case of Primary Clear Cell Carcinoma of the Urinary Bladder.

Authors:  Maithili Mandar Kulkarni; Siddhi Gaurish Sinai Khandeparkar; Avinash R Joshi; Pallavi Bhayekar
Journal:  Niger Med J       Date:  2019 Jan-Feb

7.  Lack of decorin expression by human bladder cancer cells offers new tools in the therapy of urothelial malignancies.

Authors:  Annele Sainio; Marie Nyman; Riikka Lund; Sanna Vuorikoski; Pia Boström; Matti Laato; Peter J Boström; Hannu Järveläinen
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

Review 8.  Primary Clear Cell Carcinoma of the Urinary Bladder.

Authors:  Anthony Kodzo-Grey Venyo
Journal:  Int Sch Res Notices       Date:  2014-07-02

9.  Vesical clear cell adenocarcinoma arising from endometriosis: A mullerian tumor, indistinguishable from ovarian clear cell adenocarcinoma.

Authors:  Eirwen M Miller; Ying Sun; Ingride Richardson; Marina Frimer
Journal:  Gynecol Oncol Rep       Date:  2016-08-30

10.  Clear Cell Adenocarcinoma of the Urinary Bladder Is a Glycogen-Rich Tumor with Poorer Prognosis.

Authors:  Zhengqiu Zhou; Connor J Kinslow; Peng Wang; Bin Huang; Simon K Cheng; Israel Deutsch; Matthew S Gentry; Ramon C Sun
Journal:  J Clin Med       Date:  2020-01-03       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.